Skip to content
Screener

Retained Earnings at other companies

Merck & Co. logo
Merck & Co.MRK
$66.72B+0.9%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$336.12M+29.1%
Zoetis logo
ZoetisZTS
$14.65B+13.8%
Neogen logo
NeogenNEOG
-$533M-803%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
$7.79B+7.1%
Central Garden & Pet Company logo
Central Garden & Pet CompanyCENT
$1.18B+14.7%

Other financials

Income statement

See full
Revenue$1.4B+10.2%
Gross profit$798.0M+11.9%
Net income$54.0M+391%
EPS (diluted)$0.11+450%

Balance sheet

See full
Cash & equivalents$530.0M-1.7%
Total debt$4.2B-6.2%
Total equity$6.6B-2.8%
Total assets$13.6B-1.3%

Cash flow

See full
Operating cash flow$277.0M+16.9%
CapEx$33.0M-42.1%
Free cash flow$244.0M+35.6%

Valuation

See full
Market cap$13.1B+89.0%
Enterprise value$16.81B+54.0%
P/S2.6×+1.1×

Profitability

See full
Gross margin55.4%+0.6pp
Net margin-4%-13.8pp
FCF margin7.5%-0.5pp

Returns & leverage

See full
Return on equity-3%-9.9pp
Debt / equity0.6×0.0×
Current ratio2.1×-0.5×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001739104-26-000043
Line itemJune 30, 2026December 31, 2025
Equity
Preferred stock, 1,000,000,000 shares authorized, no par value; none issued
Common stock, no par value, 5,000,000,000 shares authorized, 499,549,698 and 496,975,154 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital8,8788,870
Accumulated deficit(2,071)(2,182)
Accumulated other comprehensive loss(219)(141)
Total equity6,5886,547
Total liabilities and equity$13,561$13,358

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Elanco Animal Health Inc.'s retained earnings?
Elanco Animal Health Inc. (ELAN) reported retained earnings of -$2.07B in Q2 2026.
How has Elanco Animal Health Inc.'s retained earnings changed year-over-year?
Elanco Animal Health Inc.'s retained earnings decreased by 10.6% year-over-year, from -$1.87B to -$2.07B.
What is the long-term trend for Elanco Animal Health Inc.'s retained earnings?
Over 5 years (2020 to 2025), Elanco Animal Health Inc.'s retained earnings has grown at a 35.5% compound annual growth rate (CAGR), from -$477M to -$2.18B.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ask your AI about Elanco Animal Health Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude